ArticleMedicine2025
COVID-19 with acute myocardial infarction evaluated using multimodal imaging: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleAlthough the global impact of coronavirus disease 2019 (COVID-19) has diminished, cardiovascular complications, such as acute myocardial infarction, remain a critical concern. This case highlights the potential role of COVID-19 in destabilizing preexisting coronary plaques through systemic inflammation and hypercoagulability, offering insights into diagnostic and therapeutic strategies for similar patients. PATIENT CONCERNS: A 41-year-old woman with no prior cardiovascular risk factors presented with sudden-onset chest pain 5 days after a confirmed COVID-19 diagnosis. Initial electrocardiography showed ST-segment changes and troponin I levels were mildly elevated. DIAGNOSIS: Emergency coronary angiography revealed 90% stenosis in the middle segment of left anterior descending artery with thrombus, confirming acute anterior myocardial infarction. Optical coherence tomography identified vulnerable plaque features, including macrophages and cholesterol crystals, without plaque rupture. INTERVENTIONS AND OUTCOMES: Thrombus aspiration and optical coherence tomography-guided drug-eluted balloon angioplasty were performed. Post-procedural multimodal imaging (coronary computed tomography angiogram, cardiac magnetic resonance) demonstrated residual plaque burden and mid-myocardial late gadolinium enhancement, suggesting dual ischemic and inflammatory injuries. Intensive lipid-lowering therapy (alirocumab and rosuvastatin) and dual antiplatelet therapy were also administered. LESSONS: The disease course of the patient suggests that COVID-19 could play a role in the destabilization of atherosclerotic plaques through a high inflammatory status in the blood vessels, leading to a hypercoagulable state and acute myocardial infarction induction. Therefore, monitoring inflammatory markers and administering adequate anti-inflammatory treatments may be necessary for such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.